Search Jim Cramer's "Mad Money" trading recommendations using our exclusive "Mad Money" Stock Screener.


Did you miss last night's "Mad Money" on CNBC? If so, here are Jim Cramer's top takeaways for today's trading.

Flex (FLEX) : In an exclusive "Executive Decision" segment, Cramer sat down with Mike McNamara, CEO of Flex, formerly known as Flextronics, the contract manufacturer that Cramer characterized as an "innovation factory" for its customers. Shares of Flex are up 20% so far in 2016.

At his company's new innovation hub in New York, McNamara said customers can see a demo of a connected home, complete with lights, doors, HVAC and cars all talking to one another. All of these technologies are made possible by Flex and its many partners. Many of the core technologies used by these products, he continued, are owned by Flex.

Flex is also looking towards the future with technologies for augmented and virtual reality, which will have wide ranging applications, McNamara said, from consumer to industrial and healthcare.

McNamara said Flex is a partner in many health tracking and wearable devices and is working with the Food and Drug Administratiohn to help usher in even more devices that will not only allow doctors to monitor patients but diagnose problems from that data.

Cramer said he's always liked Flex for its great buyback and cashflow, but the company also has lots of great technology and partnerships.

Walt Disney  (DIS) : When is owning a stock for the "long term" just a cop-out for owning a loser? When is it time to admit the truth and cut your losses? Cramer said as a general rule he prefers to stick with his convictions, as long as the facts haven't changed.

When both Sprint (S) and T-Mobile (TMUS) were on the ropes, Cramer saw value, and over the years that value was realized at both companies. Sprint has $11 billion in liquidity and is growing, while T-Mobile has doubled its customer base in recent years. As long as the balance sheet is strong, companies have the ability to turn things around, Cramer said.

Now it's Walt Disney's turn in the doghouse. Many investors have given up on Disney now that the company's crown jewel, ESPN, is seeing slowing subscriber rates. But is that really all Disney has to offer?

On the company's earnings call, management noted that attendance is strong at its parks and there are many hit films in the pipeline, including the Star Wars franchise. Disneyhas the rights to plenty of live sporting events, many of which have yet to be monetized.

So just like with Sprint and T-Mobile, Cramer said Disney's best days are not behind them and he'd be a buyer for the long term.

Allergan (AGN) : In his second "Executive Decision" segment, Cramer sat down with Brent Saunders, president and CEO of Allergan, the drugmaker that just purchased Tobira Therapeutics (TBRA) for $1.7 billion.

Saunders said that Allergan didn't overpay for Tobira and the company's treatment for liver disease will meet a large unmet need if approved. He explained the mixed clinical trial results released in June were misinterpreted and the second endpoint, the one where the drug did well, is what is most important for patients. Saunders also noted that Allergan is only paying a small upfront payment to Tobira and the rest is all performance based.

Saunders also commented on his company's recently announced social contract with patients, which outlines their commitment to patients. He said that Allergan has already committed to single-digit price increases for its existing drugs and would be doing shareholders a great disservice by price gouging and having to testify before Congress.

A government takeover of healthcare is not what the industry needs, Saunders said. The industry needs self-regulation and self-discipline to do the right thing.

To read a full recap of "Mad Money" on CNBC, click here.

To watch replays of Cramer's video segments, visit the Mad Money page on CNBC.

To sign up for Jim Cramer's free Booyah! newsletter with all of his latest articles and videos please click here.

At the time of publication, Cramer's Action Alerts PLUS had a position in AGN.